# Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients

> **NCT02491905** · PHASE2 · COMPLETED · sponsor: **Huons Co., Ltd.** · enrollment: 69 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** HL tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02491905
- **Lead sponsor:** Huons Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2015-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491905, "Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02491905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*